Clinical References and Sources Wilding JPH, et al
Total revenue increased at a 6% CAGR from 2015 to 2020 , whereas over the last five years it has surged at a 21% CAGR
Efficacy Results: Treatment with BYDUREON once weekly resulted in a mean reduction in HbA1c from baseline at 26 weeks of -1.3%
Generally, the eligibility criteria include having a body mass index (BMI) that categorizes the individual as overweight or obese, typically a BMI of 30 or higher, or a BMI of 27 or higher if accompanied by weight-related health conditions such as type 2 diabetes, hypertension, or dyslipidemia
This attachment initiates a cascade of intracellular signaling events, with insulin receptor substrate - 1 (IRS - 1) serving as a critical intermediary (Walte et al., 2024)